Pel-Freez, Pyrosequencing HLA deal

Serological product developer Pel-Freez (Milwaukee, Wis.) and Pyrosequencing (SSE:PYRO A) will use PYRO A's Pyrosequencing technology to evaluate and develop DNA-based human leukocyte antigen (HLA) di...